The company is voluntarily recalling one lot of Hydrochlorothiazide Tablets USP 12.5 Mg because of a labeling mix-up. On Aug. 27, 2018, Accord Healthcare Inc. announced it was voluntarily recalling ...

To date, there have been no reports of any adverse events related to this recall. Accord Healthcare announced a voluntary recall of 1 lot of Hydrochlorothiazide tablets USP, 12.5mg, after a product ...

Aliskiren 150 mg, hydrochlorothiazide (HCTZ) 12.5 mg; tabs. Tekturna HCT combines the antihypertensive drugs aliskiren, a direct renin inhibitor, and the thiazide diuretic, hydrochlorothiazide (HCTZ).

A potentially life-threatening label mix-up has led to a nationwide recall of a high blood pressure medication, according to the U.S. Food and Drug Administration. Accord Healthcare Inc. is ...

Aliskiren and Amlodipine 150mg/5mg, 150mg/10mg, 300mg/5mg, 300mg/10mg Tablets Y52.5 Aliskiren and hydrochlorothiazide 150/12.5mg, 150/25mg or 300/12.5mg, and 300/25mg Tablets Y52.5 Aliskiren and ...

East Windsor, New Jersey, Aurobindo Pharma USA, Inc. has initiated a voluntary recall of two (2) lots (refer table below) of Quinapril and Hydrochlorothiazide Tablets USP 20mg / 12.5mg, to the ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines ...

The first fixed-dose combination involving Novartis’first-in-class oral renin inhibitor, Tekturna with hydrochlorothiazide (HCT)was approved in the USin January 2008. A single-tablet combination with ...

It is estimated that hypertension currently affects 43 million people in Japan, and this prevalence is predicted to increase as the population ages. 1 As hypertension is a major risk factor for ...

Details concerning the Hydrochlorothiazide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...